Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

'Global Allegiance' of Inspectorates Emerging (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

Drug regulatory agencies around the world are beginning to coordinate their inspection processes, which could reduce global drug manufacturers' burden of hosting multiple GMP inspections. Some are piloting joint inspections, with a pilot for active pharmaceutical ingredient manufacturers concluding next month, and a second for drug product manufacturers under way.
Advertisement

Related Content

'Global Allegiance' Of Inspectorates Emerging (Part 1 of 2)
'Global Allegiance' Of Inspectorates Emerging (Part 1 of 2)
Advertisement
UsernamePublicRestriction

Register

SC073910

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel